Cargando…

The uptake of the pharmacy-dispensed naloxone kit program in Ontario: A population-based study

BACKGROUND: Naloxone is a life-saving antidote for opioid overdoses. In June 2016, the Ontario government implemented the Ontario Naloxone Program for Pharmacies (ONPP) to enhance access to naloxone. OBJECTIVE: We examined the initial uptake of naloxone through the ONPP and characteristics of the in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choremis, Beatrice, Campbell, Tonya, Tadrous, Mina, Martins, Diana, Antoniou, Tony, Gomes, Tara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799925/ https://www.ncbi.nlm.nih.gov/pubmed/31626648 http://dx.doi.org/10.1371/journal.pone.0223589

Ejemplares similares

Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population‐based time–series analysis
por: Antoniou, Tony, et al.
Publicado: (2021)

Increasing proactive co-dispensing of take-home naloxone with prescription opioids at Ontario community pharmacies
por: Qiu Hua Chen, Autumn
Publicado: (2022)

The epidemiology of benzodiazepine-related toxicity in Ontario, Canada: a population-based descriptive study
por: Campbell, Tonya J., et al.
Publicado: (2023)

Impact of a Publicly Funded Herpes Zoster Immunization Program on the Burden of Disease in Ontario, Canada: A Population-based Study
por: Martins, Diana, et al.
Publicado: (2020)

Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis
por: Kitchen, Sophie A., et al.
Publicado: (2022)

Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population‐based propensity‐score matched cohort study
por: Gomes, Tara, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: A population-based time series analysis
por: Garg, Ria, et al.
Publicado: (2022)

Vital Signs: Pharmacy-Based Naloxone Dispensing — United States, 2012–2018
por: Guy, Gery P., et al.
Publicado: (2019)

Changing patterns of opioid initiation for pain management in Ontario, Canada: A population-based cross-sectional study
por: Gomes, Tara, et al.
Publicado: (2022)

Protocol for the Optimizing Naloxone Dispensing in Pharmacies (ONDP) Online Continuing Education Program: A Randomized Controlled Trial
por: Cid, Ashley, et al.
Publicado: (2022)

Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016
por: Meyerson, B.E., et al.
Publicado: (2018)

Effect of listing strategies on utilization of antitumor necrosis factor biologics infliximab and etanercept: a cross-sectional analysis from Ontario, Canada
por: Fenna, Jennifer, et al.
Publicado: (2021)

Impact of a publicly-funded pharmacare program policy on benzodiazepine dispensing among children and youth: a population-based natural experiment
por: Antoniou, Tony, et al.
Publicado: (2023)

Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States
por: Sohn, Minji, et al.
Publicado: (2019)

Examining the effects of COVID-19 on pharmacy dispensing of naloxone and syringes sales across Massachusetts and New Hampshire
por: Bolivar, Derek, et al.
Publicado: (2023)

Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018)

Association Between a State Law Allowing Pharmacists to Dispense Naloxone Without a Prescription and Naloxone Dispensing Rates
por: Gangal, Neha S., et al.
Publicado: (2020)

Trends in HIV pre-exposure prophylaxis uptake in Ontario, Canada, and impact of policy changes: a population-based analysis of projected pharmacy data (2015–2018)
por: Tan, Darrell H. S., et al.
Publicado: (2020)

Medical abortion kit dispensing practices of community pharmacies in Pokhara Metropolitan, Nepal
por: Dangi, Nim Bahadur, et al.
Publicado: (2021)

Varenicline and Risk of Self-Harm: A Nested Case-Control Study
por: Tadrous, Mina, et al.
Publicado: (2016)

Impact of delisting high‐strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada
por: Martins, Diana, et al.
Publicado: (2019)

Interprovincial Variation of Psychotropic Prescriptions Dispensed to Older Canadian Adults
por: Black, Cody D., et al.
Publicado: (2018)

Comparison of claims from high–drug cost beneficiaries in Ontario, Canada, and Australia: a cross-sectional analysis
por: Tadrous, Mina, et al.
Publicado: (2021)

Medication errors in community pharmacies: Evaluation of a standardized safety program
por: Ledlie, Shaleesa, et al.
Publicado: (2022)

Geographic variation and sociodemographic correlates of prescription psychotropic drug use among children and youth in Ontario, Canada: a population-based study
por: Antoniou, Tony, et al.
Publicado: (2023)

Measuring the Burden of Opioid-related Mortality in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018)

Publicly Funded Oral Chronic Hepatitis B Treatment Patterns in Ontario over 16 Years: An Ecologic Study
por: Tadrous, Mina, et al.
Publicado: (2018)

Impact of changes in opioid funding and clinical policies on rapid tapering of opioids in Ontario, Canada
por: Martins, Diana, et al.
Publicado: (2022)

Antipsychotic initiation among adults with intellectual and developmental disabilities in Ontario: a population-based cohort study
por: Gomes, Tara, et al.
Publicado: (2019)

Investigating Community Pharmacy Take Home Naloxone Dispensing during COVID-19: The Impact of One Public Health Crisis on Another
por: Daskalakis, George, et al.
Publicado: (2021)

The Risk of Ventricular Dysrhythmia or Sudden Death in Patients Receiving Serotonin Reuptake Inhibitors With Methadone: A Population-Based Study
por: Antoniou, Tony, et al.
Publicado: (2022)

Correction: Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
por: Antoniou, Tony, et al.
Publicado: (2023)

Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
por: Antoniou, Tony, et al.
Publicado: (2023)

The status of naloxone in community pharmacies across Canada
por: So, Randy, et al.
Publicado: (2020)

Medicine, Pharmacy, and Dispensing
Publicado: (1899)

Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario
por: Gomes, Tara, et al.
Publicado: (2022)

Opioid Education and Nasal Naloxone Rescue Kits in the Emergency Department
por: Dwyer, Kristin, et al.
Publicado: (2015)

Naloxone availability in independent community pharmacies in Georgia, 2019
por: Gilbert, Lauren, et al.
Publicado: (2021)

Inequities in access to primary care among opioid recipients in Ontario, Canada: A population-based cohort study
por: Gomes, Tara, et al.
Publicado: (2021)

Impact of the COVID-19 Controlled Drugs and Substances Act exemption on pharmacist prescribing of opioids, benzodiazepines and stimulants in Ontario: A cross-sectional time-series analysis
por: Chang, Ann, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d4k9hbf7ciqm7rjak4dqgtpbmk